• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Consumer Cyclical·GILLETTE.NS
Share

Gillette India Limited Stocks

₹ 8273.5Last Updated 27.05.2026

Issuer Rating

5/7
Performance

Average

Risk

Low

Recommendation

Hold

Market Cap

₹ 2.84B

₹ 8273.5
Key Takeaways

Risk factor

Negligible price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Gillette India Limited manufactures and sells grooming and oral care products in India and internationally. The company offers shaving system and cartridges, blades, toiletries, razors, and components; and toothbrushes and oral care products. It also provides female grooming products under the Gillette Venus name; and body shaving and trimming, skin care, and aftershave products. The company sells its products primarily under the Gillette and Oral-B brands. It markets and sells its products through mass merchandisers, grocery stores, membership club stores, drug stores, department stores, and high frequency stores. Gillette India Limited was incorporated in 1984 and is based in Mumbai, India.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA,

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

30.05.2026 16:01

Small caps last week: Space stocks rally, 'GLP-1 moment for hair loss', LUNR snubbed

30.05.2026 13:01

Highlights of the week: Anthropic record, new "trillionaires", Blue Origin failure

30.05.2026 03:57

One of the most popular cryptocurrencies in the world is entering the US market

30.05.2026 03:28

Barclays expects a turnaround in lagging sectors. Which stocks are likely to win?

30.05.2026 02:40

Kazakhstan can accept Iranian uranium reserves - IAEA head

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026